Donepezil for vascular cognitive impairment

Author:

Malouf Reem1,Birks Jacqueline2

Affiliation:

1. Cochrane Dementia and Cognitive Improvement Group; John Radcliffe Hospital (4th Floor, Room 4401C) Headington Oxford UK OX3 9DU

2. University of Oxford; Centre for Statistics in Medicine; Wolfson College Linton Road Oxford UK OX2 6UD

Publisher

Wiley

Subject

Pharmacology (medical)

Reference72 articles.

1. Anon Efficacy and Tolerability of donepezil in vascular dementia: positive results of a 24-week, multicentre, international, randomized, placebo-controlled clinical trial pre-publication report 2002

2. Bayer A Pratt RD Kumar D A comparison of the cognitive benefits of donepezil in patients with cortical and subcortical vascular dementia 8th Congress of the European Federation of the Neurological Sciences. Paris, France. September 4-7, 2004 2004

3. Efficacy and tolerability of donepezil in vascular dementia positive results of a 24-week multicenter internationl randomized placebo controlled trial;Black;Stroke,2003

4. Vascular dementia patients who receive donepezil treatment for 12 to 18 months maintain cognitive benefits;Doody;NeuroBiology of Aging,2004

5. Donepezil slows functional deterioration in patients with vascular dementia;Geldmacher;European Journal of Neurology,2002

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3